Novel germline mutation in the transmembrane domain of HER2 in familial lung adenocarcinomas.
about
Role of HER2 in NSCLCAnalysis of different HER-2 mutations in breast cancer progression and drug resistanceFamilial Lung Cancer: A Brief History from the Earliest Work to the Most Recent StudiesFamilial risk for lung cancerCopy number analysis of whole-genome data using BIC-seq2 and its application to detection of cancer susceptibility variants.Genomic Sequencing Identifies ELF3 as a Driver of Ampullary Carcinoma.Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.Targeted therapy in NSCLC driven by HER2 insertionsTrends and Characteristics of Young Non-Small Cell Lung Cancer Patients in the United States.A germline mutation in SRRM2, a splicing factor gene, is implicated in papillary thyroid carcinoma predispositionSequencing study on familial lung squamous cancer.Targeted DNA Sequencing Detects Mutations Related to Susceptibility among Familial Non-medullary Thyroid CancerAntitumor effect of afatinib, as a human epidermal growth factor receptor 2-targeted therapy, in lung cancers harboring HER2 oncogene alterations.Comprehensive investigation of oncogenic driver mutations in Chinese non-small cell lung cancer patientsInteraction of cytokeratin 19 head domain and HER2 in the cytoplasm leads to activation of HER2-Erk pathway.Genetic susceptibility variants for lung cancer: replication study and assessment as expression quantitative trait loci.Germline mutations predisposing to non-small cell lung cancer.Lung Cancer in Never Smokers.New Insights into Molecular Organization of Human Neuraminidase-1: Transmembrane Topology and Dimerization Ability.Germline mutations causing familial lung cancer.Comprehensive benchmarking of SNV callers for highly admixed tumor data.Therapeutic Potential of Afatinib for Cancers with ERBB2 (HER2) Transmembrane Domain Mutations G660D and V659E.Antitumor activity of pan-HER inhibitors in HER2-positive gastric cancer.Mechanisms of receptor tyrosine kinase activation in cancer.Non-small-cell lung cancer.Activating HER2 mutations as emerging targets in multiple solid cancers.Inherited lung cancer syndromes targeting never smokers
P2860
Q26781683-A3A9EE36-32FF-48BD-8E1F-653AF23DEC53Q26797471-AB7D13D4-56E0-4463-BB93-548FF37E1BE4Q29248944-43459D3B-B6AE-44AD-A8A8-4B7A4C05634EQ29249088-1D4D611F-7D49-4EC8-9AF8-0E93B0923747Q31105539-49857BB7-27A8-4494-8EF0-D24DCEB0B79BQ33888432-01273B52-392E-41C3-AE90-A34C5B04B04CQ34103963-CC7F4807-F868-4694-B59B-89061F55A07AQ35200528-D8316B28-F23C-4D3A-9A06-0994F522C7ACQ35646413-7DC730FE-E289-4BAD-AF4E-70A92152AC60Q35809227-E39F3723-BB77-4CA3-AD16-C6C1CDE239B3Q36085898-270CAFF6-26D2-4EA2-B99E-408FBDDB847DQ36245933-D9719F80-5C32-42CD-B625-3F3B521B52EAQ36495936-3B3F1FA4-EF94-46E7-BB91-95DED1E5E6B4Q36544077-B294213E-7C41-4A86-AE31-336807E0F3F9Q37529089-2C6D00CD-F3BA-433D-A3F5-7396C7C91448Q37633874-898FD235-424F-4FD3-A62F-06B800FCA28EQ38392359-A28C6526-151B-40E1-A63D-62CFE35A34A8Q38669269-6E157E40-1884-4216-B405-87D63317CE44Q39130919-4BEEC18D-05E5-47CB-99A0-F3048D5E7A84Q40732783-8FA6C259-0510-49E3-BA8A-CBE55901893DQ42705197-2ED081CC-1988-4E4E-9747-4CB44D84064CQ47214722-E0D36A73-A3F8-4DF3-9EAC-57DAD364A704Q49710712-DB2B546B-2788-4EE0-9940-292561B48A18Q49888000-4587FBBC-636E-48A6-8AE9-1526B7FCE324Q51021428-0C46DA25-3331-4778-B1C8-C5E7639723D8Q54986604-6291C774-0A83-43F5-8556-6DD838DC2142Q58804391-9EE94CA0-5EDA-4E65-AF5C-7038E269E87E
P2860
Novel germline mutation in the transmembrane domain of HER2 in familial lung adenocarcinomas.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Novel germline mutation in the ...... familial lung adenocarcinomas.
@en
Novel germline mutation in the ...... familial lung adenocarcinomas.
@nl
type
label
Novel germline mutation in the ...... familial lung adenocarcinomas.
@en
Novel germline mutation in the ...... familial lung adenocarcinomas.
@nl
prefLabel
Novel germline mutation in the ...... familial lung adenocarcinomas.
@en
Novel germline mutation in the ...... familial lung adenocarcinomas.
@nl
P2093
P2860
P50
P356
P1476
Novel germline mutation in the ...... familial lung adenocarcinomas
@en
P2093
Fumihiko Matsuda
Hiromasa Yamamoto
Junichi Soh
Katsuyuki Kiura
Koichi Ichimura
Koichiro Higasa
Masakiyo Sakaguchi
Masashi Furukawa
Nagio Takigawa
Shinichi Toyooka
P2860
P304
P356
10.1093/JNCI/DJT338
P407
P577
2013-12-07T00:00:00Z